Go to industries

Healthcare

Critical guidance on your journey

With new and groundbreaking technology constantly challenging the status quo, the healthcare industry is progressing by leaps and bounds. But in an industry built on regulations, strategic partnerships are often the key to successfully developing businesses. Our passionate advisors, backed by sub-sector teams globally, use their deep expertise in M&A, growth equity and ECM, debt advisory and corporate finance services to find your competitive edge, navigate local customs and help you create the most suitable strategy.

Contact advisor
Worldwide
472
deals closed in Healthcare
Worldwide
Explore all our industry-related deals
Go to deals
Saneca Pharmaceuticals, a.s. has acquired Suir Pharma Ireland
Healthcare | Private Equity

Saneca Pharmaceuticals, a.s. has acquired Suir Pharma Ireland

Saneca Pharmaceuticals, a.s. (Saneca) has acquired Suir Pharma Ireland from mutares AG, an industrial holding company. Financial details have not been disclosed.

Learn more
Chirana T. Injecta, a.s. has acquired Vitrex Medical A/S
Healthcare

Chirana T. Injecta, a.s. has acquired Vitrex Medical A/S

Chirana T. Injecta, a.s. has announced the acquisition of Vitrex Medical A/S, the Danish disposable medical and laboratory devices manufacturing company developing, producing and selling disposable articles, primarily for blood sample taking and analysis. Financial details have not been disclosed.

Learn more
Chirana T. Injecta, a.s. has acquired Chirmax, s.r.o.
Healthcare

Chirana T. Injecta, a.s. has acquired Chirmax, s.r.o.

Chirana T. Injecta, a.s. has acquired a 100% stake in Chirmax, s.r.o., the Czech manufacturer of surgical suture material, for an undisclosed consideration.

Learn more
“During the last 12 years, I have made move UP what it is today, a valued partner in physical fitness for health insurers and employers. Acture shares my vision of physical health. I look forward to developing the concept of total welfare management together with Acture in Germany and the rest of Europe. I want to express my heartfelt gratitude to the Oaklins team, our invaluable partner throughout this process. Their unwavering dedication and strategic guidance played a pivotal role in navigating the complexities of this deal and we sincerely appreciate their substantial operational support. We are confident and ready to embrace a prosperous future as an integral part of the Acture family.”

Jan-Frederik Kolthoff

Founder and CEO, move UP Gesellschaft für Gesundheitsmanagement mbH

Read more
Example: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=AT&includes=featured_images,tags&language=de-AT&limit=3&tags=healthcare 
Ours: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=CZ&includes=featured_images,tags&language=en&limit=1&tags=healthcare

Strategic moves and sector-specific trends

QUARTERLY M&A ACTIVITY: From securing growth capital to finding future partners, Oaklins' Q3 deals reflect strategic navigation in dynamic industry landscapes.

Learn more

Talk to our local advisors

Miloš Čebík

Director
Prague, Czech Republic
Oaklins WOOD & Co.

Michal Staron

Managing Director
Bratislava, Slovakia
Oaklins WOOD & Co.

Meet our global industry specialists

Antoine Lemaire

Partner
Paris, France
Oaklins France

Robert Boersma

Partner
Amsterdam, Netherlands
Oaklins Netherlands

Stuart Goodman

Partner
London, United Kingdom
Oaklins Evelyn Partners

Michael Jewell

Partner
London, United Kingdom
Oaklins Cavendish

Michael S. Goldman

Managing Director
New York, United States
Oaklins TM Capital